Drug or treatment
Erdafitinib clinical trials
As of November 12, 2026, Find a Trial lists 2 clinical trials of Erdafitinib that are recruiting, at sites in 20 countries (most in France (2), Italy (2), Spain (2)). By phase: Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 20Countries
All recruiting trials (2)
-
Erdafitinib with or without Cetrelimab for muscle-invasive bladder cancer
This study is testing if a new drug called erdafitinib, alone or with another drug called cetrelimab, can help people with muscle-invasive bladder cancer who can’t take certain chemotherapy drugs before their surgery.
-
Comparing TAR-210 to standard chemotherapy for bladder cancer treatment
This study is testing if a new treatment called TAR-210 can help people with intermediate-risk bladder cancer live longer without their cancer coming back compared to standard chemotherapy options.
Quick answers
How many clinical trials of Erdafitinib are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 20 countries. The most sites are in France (2 trials), Italy (2 trials), Spain (2 trials), United Kingdom (2 trials), Argentina (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.